Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving medicines use in people with polypharmacy in primary care: a synopsis from the IMPPP cluster-RCT with pilot-feasibility study.

Health and social care delivery research·2026
Same author

Duration of Care in Early Intervention in Psychosis Services: A Multi-Perspective Qualitative Study.

Early intervention in psychiatry·2026
Same author

Attention-deficit hyperactivity disorder in children and young persons during the COVID-19 pandemic. A temporal trends analysis of electronic heath records in Greater Manchester, England.

JCPP advances·2026
Same author

Moving on from patient safety incidents: a qualitative study exploring GP perspectives in England.

The British journal of general practice : the journal of the Royal College of General Practitioners·2026
Same author

Professional Governance and the Limits of Recognition.

Journal of evaluation in clinical practice·2026
Same author

Companions' involvement in older patients' healthcare: A scoping review of companions' roles and impacts before, during, and following medical encounters.

Patient education and counseling·2026

Related Experiment Videos

Primary Care Cardiovascular Risk Reduction after Pregnancy Complications: A Qualitative Systematic Review.

Victoria Jane Hodges1,2, Saminah Shareef3, Carolyn A Chew-Graham4

  • 1Keele University, Medicine, Newcastle-under-Lyme, United Kingdom b.hodges@keele.ac.uk.

The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|June 1, 2026
PubMed
Summary

Women

Keywords:
Health EquityHeart Disease Risk FactorsPostpartum PeriodPregnancy ComplicationsPrimary Care

Related Experiment Videos

Area of Science:

  • Reproductive Health
  • Cardiovascular Disease Prevention
  • Behavioral Science

Background:

  • Adverse pregnancy outcomes (APOs) impact 30% of pregnancies, increasing lifelong cardiovascular disease (CVD) risk.
  • Behavioral interventions are explored for mitigating this elevated CVD risk post-APO.

Purpose of the Study:

  • To systematically review qualitative literature on women's experiences with behavioral change for CVD risk reduction after APOs.
  • To focus on health equity within these experiences.

Main Methods:

  • Qualitative systematic review of studies from high-income countries with universal healthcare access.
  • Systematic search of PubMed, Embase, and CINAHL databases.
  • Thematic synthesis mapped onto the COM-B framework for analysis.

Main Results:

  • Eighteen studies with 339 women were included; demographic data on ethnicity and socioeconomic status were often missing.
  • Women's capability, opportunity, and motivation influenced behavior change, with delayed recovery and competing demands hindering progress.
  • Integrated family-based changes, awareness of CVD risk, and personalized advice enhanced motivation; tailored follow-up supported engagement, particularly for minority ethnic and socioeconomically disadvantaged groups.

Conclusions:

  • Preventing CVD after APOs necessitates structured, system-level support prioritizing family-based behavior change.
  • Underrepresentation of high-risk groups in research highlights the need for co-produced interventions to prevent widening health inequalities.